IMTX
Immatics N.V. · Healthcare · Biotechnology
Momentum-inputs (vergelijkbare managers): breedte van houders 0.0% · aandelenstroom +20.5% · netto nieuwe posities 0.0% · formule
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q4 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 35 | 0 | 11.76M | $118.95M | +4 | −4 |
| Q1 2026 | 35 | +3 | 20.34M | $199.85M | +5 | −2 |
| Q4 2025 | 31 | 0 | 13.12M | $137.78M | n/a | n/a |
| Q3 2025 | 11 | +1 | 6.87M | $58.55M | +2 | −1 |
| Q2 2025 | 7 | -1 | 7.51M | $36.14M | n/a | −1 |
| Q1 2025 | 7 | -3 | 10.10M | $41.98M | n/a | −3 |
| Q4 2024 | 10 | +1 | 14.90M | $100.53M | +2 | −1 |
| Q3 2024 | 8 | 0 | 16.54M | $184.94M | +1 | −1 |
| Q2 2024 | 8 | n/a | 15.53M | $176.70M | n/a | n/a |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Morgan Stanley ✦ | 2.09M | -5.2% | $21.94M | 0.0% | ▼ Trim | 2 | SEC ↗ ×6 |
| 2 | Point72 Asset Management ✦ | 1.75M | +1384.2% | $18.42M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | Citadel Advisors ✦ | 1.71M | +184.3% | $18.01M | 0.0% | ▲ Add | 7 | SEC ↗ |
| 4 | Wellington Management ✦ | 1.64M | +8.1% | $17.17M | 0.0% | ▲ Add | 7 | SEC ↗ ×3 |
| 5 | Alyeska Investment Group, L.P. | 789.16K | n/a | $8.29M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | T. Rowe Price ✦ | 748.03K | +3.2% | $7.86M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 7 | Aberdeen Group plc | 714.57K | n/a | $7.50M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | Balyasny Asset Management L.P. | 592.43K | n/a | $6.22M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | UBS Group AG | 563.46K | n/a | $5.92M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 10 | Td Asset Management Inc | 500.72K | n/a | $5.26M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | State Street Global Advisors ✦ (passief) | 444.66K | +103.5% | $4.67M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 12 | Goldman Sachs Group ✦ | 323.02K | +69.3% | $3.39M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 13 | Northern Trust Corp | 203.45K | n/a | $2.14M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 14 | Qube Research & Technologies Ltd | 147.33K | n/a | $1.55M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | JPMorgan Chase ✦ | 146.97K | -46.0% | $1.54M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 16 | Geode Capital Management ✦ (passief) | 134.76K | +96.1% | $1.42M | 0.0% | ▲ Add | 7 | SEC ↗ |
| 17 | Bnp Paribas Financial Markets | 116.65K | n/a | $1.22M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | Jane Street Group, Llc | 104.93K | n/a | $1.10M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 19 | Millennium Management ✦ | 83.12K | -88.5% | $872,781 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 20 | Citigroup Inc | 56.37K | n/a | $591,854 | 0.0% | n/c | 1 | SEC ↗ |
| 21 | Tudor Investment Corp Et Al | 54.72K | n/a | $574,560 | 0.0% | n/c | 1 | SEC ↗ |
| 22 | Manufacturers Life Insurance… | 55.30K | n/a | $556,871 | 0.0% | n/c | 1 | SEC ↗ |
| 23 | Mercer Global Advisors Inc /Adv | 29.99K | n/a | $314,864 | 0.0% | n/c | 1 | SEC ↗ |
| 24 | Barclays Plc | 28.18K | n/a | $295,943 | 0.0% | n/c | 1 | SEC ↗ |
| 25 | BlackRock ✦ (passief) | 25.55K | -89.2% | $268,318 | 0.0% | ▼ Trim | 3 | SEC ↗ ×2 |
| 26 | Susquehanna International Group, Llp | 17.02K | n/a | $178,752 | 0.0% | n/c | 1 | SEC ↗ |
| 27 | Mitsubishi UFJ Asset Management… | 16.95K | n/a | $177,180 | 0.0% | n/c | 1 | SEC ↗ |
| 28 | Bank Of America Corp /De/ | 13.55K | n/a | $142,232 | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 29 | Mariner, LLC | 13.40K | n/a | $140,682 | 0.0% | n/c | 1 | SEC ↗ |
| 30 | Osaic Holdings, Inc. | 5.17K | n/a | $54,337 | 0.0% | n/c | 1 | SEC ↗ |
| 31 | Wells Fargo & Company/Mn | 651 | n/a | $6,836 | 0.0% | n/c | 1 | SEC ↗ |
"Hun weging" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die manager: de overtuigingsmaatstaf. ✦ = gecureerde manager.
Nieuwe kopers
| Geen nieuwe bijgehouden kopers dit kwartaal. |
Verlaten
| Geen bijgehouden uitstappen dit kwartaal. |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 82 houders, 108.05M aandelen, $842.81M gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect het vaakst nog meer bezitten: aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Director · 863.06K aand @ 8.69 · $7.50M
Open-market verkopen (S)
Geen open-market insider-verkopen in ons dekkingsvenster.
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie
7.6% van klasse · Originele SEC-indiening bekijken ↗